These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2729944)

  • 1. Pharmacokinetics of single-dose cefmetazole following intramuscular administration of cefmetazole sodium to healthy male volunteers.
    Ko H; Novak E; Peters GR; Bothwell WM; Hosley JD; Closson SK; Adams WJ
    Antimicrob Agents Chemother; 1989 Apr; 33(4):508-12. PubMed ID: 2729944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of intravenously administered cefmetazole and cefoxitin and effects of probenecid on cefmetazole elimination.
    Ko H; Cathcart KS; Griffith DL; Peters GR; Adams WJ
    Antimicrob Agents Chemother; 1989 Mar; 33(3):356-61. PubMed ID: 2729930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cefmetazole administered intramuscularly and intravenously to healthy adults.
    Rodriguez-Barbero J; Mariño EL; Dominguez-Gil A
    Antimicrob Agents Chemother; 1985 Oct; 28(4):544-7. PubMed ID: 3865631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and dose proportionality of cefmetazole in healthy young and elderly volunteers.
    Borin MT; Peters GR; Smith TC
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1944-8. PubMed ID: 2291659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of intravenous cefmetazole with emphasis on comparison between predicted theoretical levels in tissue and actual skin window fluid levels.
    Tan JS; Salstrom SJ; Signs SA; Hoffman HE; File TM
    Antimicrob Agents Chemother; 1989 Jun; 33(6):924-7. PubMed ID: 2764542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral doses.
    Tartaglione TA; Raffalovich AC; Poynor WJ; Espinel-Ingroff A; Kerkering TM
    Antimicrob Agents Chemother; 1986 Jan; 29(1):62-6. PubMed ID: 2942101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of the pharmacokinetics of N-methylthiotetrazole following administration of cefoperazone, cefotetan, and cefmetazole.
    Welage LS; Borin MT; Wilton JH; Hejmanowski LG; Wels PB; Schentag JJ
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2369-74. PubMed ID: 2088192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of cefmetazole in healthy volunteers and patients with impaired renal function.
    Halstenson CE; Guay DR; Opsahl JA; Hirata CA; Olanoff LS; Novak E; Ko H; Cathcart KS; Matzke GR
    Antimicrob Agents Chemother; 1990 Apr; 34(4):519-23. PubMed ID: 2344159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefmetazole in normal subjects and in patients with impaired renal function.
    Ohkawa M; Orito M; Sugata T; Shimamura M; Sawaki M; Nakashita E; Kuroda K; Sasahara K
    Antimicrob Agents Chemother; 1980 Sep; 18(3):386-9. PubMed ID: 6932824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers.
    Gordi T; Frohna P; Sun HL; Wolff A; Belardinelli L; Lieu H
    Clin Pharmacokinet; 2006; 45(12):1201-12. PubMed ID: 17112296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cefotiam administered intravenously and intramuscularly to healthy adults.
    Brisson AM; Bryskier A; Millerioux L; Fourtillan JB
    Antimicrob Agents Chemother; 1984 Oct; 26(4):513-8. PubMed ID: 6097166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, pharmacodynamics and safety of febuxostat, a non-purine selective inhibitor of xanthine oxidase, in a dose escalation study in healthy subjects.
    Khosravan R; Grabowski BA; Wu JT; Joseph-Ridge N; Vernillet L
    Clin Pharmacokinet; 2006; 45(8):821-41. PubMed ID: 16884320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder inhalation via Aerolizer.
    Lecaillon JB; Kaiser G; Palmisano M; Morgan J; Della Cioppa G
    Eur J Clin Pharmacol; 1999 Apr; 55(2):131-8. PubMed ID: 10335908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of intravenous, intramuscular, and subcutaneous nalbuphine in healthy subjects.
    Lo MW; Lee FH; Schary WL; Whitney CC
    Eur J Clin Pharmacol; 1987; 33(3):297-301. PubMed ID: 3691617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of physostigmine intramuscularly administered to guinea pigs.
    Lukey BJ; Parrish JH; Marlow DD; Clark CR; Sidell FR
    J Pharm Sci; 1990 Sep; 79(9):796-8. PubMed ID: 2273462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and dose proportionality of cefpimizole in normal humans after intramuscular administration.
    Lakings DB; Novak E; Friis JM; Lunan CM; Paxton LM
    Antimicrob Agents Chemother; 1986 Feb; 29(2):271-7. PubMed ID: 3717932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic properties of single- and multiple-dose of dapagliflozin, a selective inhibitor of SGLT2, in healthy Chinese subjects.
    Yang L; Li H; Li H; Bui A; Chang M; Liu X; Kasichayanula S; Griffen SC; Lacreta FP; Boulton DW
    Clin Ther; 2013 Aug; 35(8):1211-1222.e2. PubMed ID: 23910664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.